Search

In recent years, the concept of public pedagogy has increasingly influenced the study of continuing education, drawing attention to ways in which adults access resources from popular culture and learn without the involvement of educational institutions. Reading relationship self-help books has become a prominent component of popular culture. There are two predominant scholarly interpretations of relationship books for women. One argues that such books have "abducted" feminism, because, while cloaked in egalitarian rhetoric about relationships between men and women, they actually encourage women to adopt characteristically male approaches to relationships. The other claims that such books are "anti-feminist," because they encourage women to nurture satisfying relationships by adopting traditional feminine roles. We explore these interpretations through reporting the results of twenty-four qualitative interviews. Only a minority of readers reported experiences consistent with existing interpretations of the genre. Most readers displayed complex combinations of learning experiences--some of which were consistent with feminist principles, while others reflected a subtle normalization of gender inequalities. We conclude that understanding the impact of self-help books, among other forms of public pedagogy, requires moving beyond textual analysis, to engaging readers in conversation about how reading has influenced their sense of themselves and their relationships.

The Thelon Basin located in Nunavut, Canada, shares many similarities with the U-producing Athabasca Basin in Saskatchewan. The Kiggavik project area, located near the northeastern edge of the Thelon Basin, contains U deposits and showings along the ∼30 km long NE-SW Kiggavik - Andrew Lake structural trend. The Andrew Lake deposit is near the southern end of this trend. Pre-mineralization is characterized by quartz ± carbonate veins that occupy fault systems later reactivated as conduits for U-mineralizing fluids. A four-phase genetic model is proposed for the Andrew Lake deposit. Phase 1 comprises vein-style uraninite (U1; 1031 ± 23 Ma) that is associated with illite and hematite, and contains variable PbO contents (0.2-9.5 wt.%). Phase 2 is characterized by altered uraninite (U2; ∼530 Ma) that is associated with coffinite. Altered uraninite (U3; <1 Ma) characterizes phase 3 and occurs as centimetre-scale 'roll-fronts'. In phase 4, all three uraninite stages, and coffinite, are altered to boltwoodite. Although the oldest uraninite U-Pb age is ∼1030 Ma, illite associated with the U mineralization gives 40Ar/39Ar ages of 941 ± 31 and 1330 ± 36 Ma. The younger age is similar to the age for U1, suggesting that there was a fluid event that either precipitated U1 or reset the U-Pb isotopic system at ∼1000 Ma. While the older age for illite (1330 Ma) does not correlate with Andrew Lake U-Pb uraninite ages, it does correlate with ages previously reported for uraninite and clay alteration minerals in the Kiggavik area. [ABSTRACT FROM AUTHOR]

Unlabelled: Loss of bone mineral density occurs after discontinuation of teriparatide, if no subsequent treatment is given. Sequential raloxifene prevented rapid bone loss at lumbar spine and further increased bone mineral density (BMD) at femoral neck, whether raloxifene was started immediately or after a one-year delay following teriparatide treatment., Introduction: We compared the sequential effects of raloxifene treatment with a placebo on teriparatide-induced increases in bone mineral density (BMD). A year of open-label raloxifene extended the study to assess the response with and without delay after discontinuation of teriparatide., Methods: Following a year of open-label teriparatide 20 mug/day treatment, postmenopausal women with osteoporosis were randomly assigned to raloxifene 60 mg/day (n = 157) or a placebo (n = 172) for year 2, followed by a year of open-label raloxifene. BMD was measured by dual energy x-ray absorptiometry., Results: The raloxifene and placebo groups showed a decrease in lumbar spine (LS) BMD in year 2 for raloxifene and placebo groups (-1.0 +/- 0.3%, P = 0.004; and -4.0 +/- 0.3%, P < 0.001, respectively); the decrease was less with raloxifene (P < 0.001). Open-label raloxifene treatment reversed the LS BMD decrease with a placebo, resulting in similar decreases 2 years after randomization (-2.6 +/- 0.4% (raloxifene-raloxifene) and -2.7 +/- 0.4% (placebo-placebo). At study end, LS and femoral neck (FN) BMD were higher than pre-teriparatide levels, with no significant differences between the raloxifene-raloxifene and placebo-raloxifene groups, respectively (LS: 6.1 +/- 0.5% vs. 5.1 +/- 0.5%; FN: 3.4 +/- 0.6% vs. 3.0 +/- 0.5%)., Conclusion: Sequential raloxifene prevented rapid bone loss at the LS and increased FN BMD whether raloxifene was started immediately or after a one-year delay following teriparatide treatment.